With our extensive experience in portfolio identification and abundant market intelligence, we have built a well-balanced portfolio consisting of:
Niche products with limited or, in some cases, no generic competition
Genericised products that have undergone or are expected to undergo consolidation on the pricing and / or supply fronts.
Products expected to go off-patent in the years to come
Our product portfolio is focussed on markets like US, Europe, Canada, Australia and South Africa.
The initial product portfolio comprises predominantly of oral solids in addition to a few liquid orals. We have also identified a portfolio of injectable products that will be taken up for development shortly.
Please get in touch with us for further details about our portfolio.